Skip to main content

Select Drug Profiles

Practice Management

Health Resource Utilization and Direct Costs Associated with Angina for Patients with Coronary Artery Disease in a US Managed Care Setting

Judy Kempf, PhD, Erin Buysman, MS, Diana Brixner, RPh, PhD, Michael F. Murphy, MD, PhD

Stakeholder Perspective

Medical Claims Data Can Inform Coverage Decisions in Managed Care Health Plans

Adapting to Market Changes: Beyond Healthcare Reform

F. Randy Vogenberg, PhD, FASHP

Practice Management

Review of Strategies to Enhance Outcomes for Patients with Type 2 Diabetes: Payers’ Perspective

Rhonda Greenapple, MSPH

Stakeholder Perspective

We Must All Engage in the Diabetes Challenge: A Lifelong Journey, with No Silver Bullet

by Charles E. Collins, Jr., MS, MBA

The Era of Personalized Medicine in Oncology: Novel Biomarkers Ushering in New Approaches to Cancer Therapy

Steve Stricker, PharmD, MS, BCOP

Practice Management

Building Your Automated Bundled Payment for an Episode-of-Care Initiative

Douglas Moeller, MD

Drugs in Phase 3 Clinical Trials for Type 2 Diabetes

Conference Highlights ADA

Cutting-Edge Data Presented at ADA 2011 Highlight the Diabetes–Cardiovascular Disease Link

In Search of Stakeholder Collaboration to Stem the Cardiometabolic Epidemic

Dalia Buffery, MA, ABD

Original Research

Obesity in the Workplace: Impact on Cardiovascular Disease, Cost, and Utilization of Care

Alberto M. Colombi, MD, MPH, G. Craig Wood, MS

Stakeholder Perspective

Employers’ Obesity Initiatives in the Workplace: A Wakeup Call for Health Plans

by Wayne M. Lednar, MD, PhD

Original Research

A Call to Action: Responding to the Future Forecasting of Cardiovascular Disease in America

Robert Lee Page ii, PharmD, MSPH, FAHA, FCCP, FASCcP, FASHP, BCPS, Vahram Ghushchyan, PhD, Kavita Nair, PhD

Stakeholder Perspective

Prevention Efforts before Disease Strikes the Key to a Healthy Population of Young Adults

by James T. Kenney, RPh, MBA

Page 213 of 244
Results 2121 - 2130 of 2438